generics

Merger of Drugmakers Valeant, Actavis on Hold

AstraZeneca Q1 Sales Tumble as Generic Losses Bite Deep

South Africa Seeks to Close Drug Patent Loophole

UK Watchdog Accuses GSK Over 'Pay-for-delay' Drug Deals

Abbott Devices, Generics Struggle

Actavis to Sell Generic Yaz Birth Control After Ruling

Novartis Loses Landmark India Cancer Drug Patent Case

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

AstraZeneca Settles Crestor Patent Dispute

Roche Stays a Step Ahead of Copycat Drugmakers

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

Par to Pay $45 Million, End US Probes Over AIDS Appetite Drug

Generics Brought Down Common Drug Prices in 2012

India Rules Against Bayer in Cancer Drug Patent Case

Hikma Eyes Options for Injectables Business

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Amgen Biosimilar Push Takes Aim at Blockbusters

EU Regulators Charge J&J, Novartis Over Dutch Painkiller Delay

Endo Health in Talks with Potential Buyers

Eli Lilly Q4 Profits Hurt by Generic Competition

Actavis, Formerly Watson, Sees 2013 Profit Growth

Abbott Results Bode Well for Spun-off AbbVie

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

US FDA New Drug Approvals Hit 16-Year High in 2012

Number of New Drugs Picks Up in Europe and U.S.

With Teva at Crossroads, New CEO Set to Unveil Vision

Top EU Court Upholds AstraZeneca Fine Over Ulcer Drug

Teva's 2013 Forecast Is Below Wall Street Estimates

Bayer Sues Lupin Over Generic Birth Control Pill

Ranbaxy Halts Generic Lipitor Production After Recall

India's Ranbaxy Recalls Generic Lipitor in U.S.

Cipla to Bid $215 Million for Control of South Africa Affiliate

Topics • Technology

Orphan Drugs

Novartis CEO Says U.S. Plant Gets FDA Clearance

92 more articles

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Interview

Navigating Uncertainty and Driving Innovation

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

SchüllerConsulting

Fitch Ratings

Arthur D. Little

Deutsche Post DHL

F. Hoffmann-La Roche Ltd

Thomson Reuters

Camelot Management Consultants AG

ARC Advisory Group GmbH & Co KG

CMS Advisors GmbH & Co. KG

Camelot Management Consultants AG

Porsche Consulting

Saltigo GmbH

Enigma Marketing Research